Unrestricted cell cycling and cancer

Nature Medicine

Volumn 1, Issue 12, 1995, Pages 1245-1246

  Strauss, Michael ^a,b   Lukas, Jiri ^b   Bartek, Jiri ^b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGENESIS; CELL CYCLE G1 PHASE; HUMAN; MITOSIS; MITOSIS INHIBITION; NONHUMAN; PRIORITY JOURNAL; RESTRICTION SITE; SHORT SURVEY;

ANIMAL; CYCLIN-DEPENDENT KINASES; CYCLINS; G1 PHASE; HUMAN; NEOPLASMS; ONCOGENES; REPRESSOR PROTEINS; RETINOBLASTOMA PROTEIN; SIGNAL TRANSDUCTION;

EID: 0028886364     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1295-1245     Document Type: Note

References (14)

1. Pardee, A. B. Gl events and regulation of cell proliferation, Scienc 246, 603-608 (1989).
2. Pardee, A. B. A restriction point for control of normal animal cell proliferation. Proc. nat. Acad, Sci. U. S. A 71, 1286-1290 (1974).
3. Weinberg, R. A. The retinoblastoma protein and cell cycle control. Cel 81, 323-330 (1995).
4. Sherr, C. J. & Roberts, J. M. inhibitors of mammalian G, cyclin-dependent kinases. Genes De. 9, 1149-1163 (1995)
5. Baldin, V., Lukas, J., Marcote, M. J., Pagano, M. & Draetta G. Cyclin D1 is a nuclear protein required for cell cycle progression in Gl. Genes Dev. 7, 812-821 (1993).
6. Lukas, J., Bartkova, J, Rohde, M., Strauss, M. & Bartek, J. Cyclin D1 is dispensable for Gl control in retinoblastoma gene-deficient cells independently of cdk4 activity, Molec. cell. Biol 15, 2600-2611 (1995)
7. Lukas, J. et al. Retínobłastoma-protein-dependent cell-cycle inhibition by the tumor suppressor pi6. Natur 375, 503-506 (1995).
8. Koh, J., Enders, G. H., Ðynlacht, B. & Harlow, E. Tumour-derived pi6 alleles encoding proteins defective in cell-cycle inhibition. Natur 375, 506-510 (1995).
9. PSk3/cdk4) for mammalian D type Gl cyclin s. Cell 71, 323-334 (1992)
10. Bates, S. & Peters, G. Cyclin D1 as a cellular protooncogene. Sem. Cancer Bio 6, 73-82 (1995).
11. Schmidt, E. E., Ichimura, K., Reifenberger, G. & Collins, V. P. CDKN2 (p 16/MTS 1) gene deletion or CDK4 amplification occurs in the majority of glioblastoma. Cancer Res 54, 6321-6324 (1994).
12. INK42-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Scienc 269, 1281-1284 (1995).
13. Merlo, A. et al. 5’ CpG island methylation is associated with transcriptional silencing of the tumor suppressor pl6/CDKN2/MTSl in human cancers. Nature Med 1, 686-692 (1995).
14. K4/crîKN2and cyclin D1 cooperate to deregulate G, control. Cancer Res 55, 4818-4823 (1995).